DE69130586T2 - Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten - Google Patents

Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten

Info

Publication number
DE69130586T2
DE69130586T2 DE69130586T DE69130586T DE69130586T2 DE 69130586 T2 DE69130586 T2 DE 69130586T2 DE 69130586 T DE69130586 T DE 69130586T DE 69130586 T DE69130586 T DE 69130586T DE 69130586 T2 DE69130586 T2 DE 69130586T2
Authority
DE
Germany
Prior art keywords
compound
give
keto
dihydro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130586T
Other languages
German (de)
English (en)
Other versions
DE69130586D1 (de
Inventor
Ryuji Nishinomiya-Shi Hyogo-Ken Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69130586D1 publication Critical patent/DE69130586D1/de
Application granted granted Critical
Publication of DE69130586T2 publication Critical patent/DE69130586T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69130586T 1990-05-01 1991-04-29 Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten Expired - Lifetime DE69130586T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11613990 1990-05-01

Publications (2)

Publication Number Publication Date
DE69130586D1 DE69130586D1 (de) 1999-01-21
DE69130586T2 true DE69130586T2 (de) 1999-06-17

Family

ID=14679704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130586T Expired - Lifetime DE69130586T2 (de) 1990-05-01 1991-04-29 Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten

Country Status (7)

Country Link
US (1) US5164415A (enExample)
EP (1) EP0455448B1 (enExample)
KR (1) KR970005174B1 (enExample)
AT (1) ATE174221T1 (enExample)
CA (1) CA2041417C (enExample)
DE (1) DE69130586T2 (enExample)
TW (1) TW209170B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
CA2279267C (en) * 1997-11-28 2010-01-12 R-Tech Ueno, Ltd. Use of 15-ketoprostaglandin e compounds as endothelin antagonist
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
EP1220849B1 (en) 1999-10-15 2004-05-19 Sucampo AG Bicyclic compounds composition and method for stabilizing the same
JP4183943B2 (ja) * 2000-04-06 2008-11-19 スキャンポ・アーゲー １５−ケトプロスタグランジンを含む胆汁分泌促進剤組成物
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
PT1389116E (pt) * 2001-05-18 2008-04-11 Sucampo Ag Composição de indução catártica
EP1420794B1 (en) * 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
MXPA05006981A (es) * 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
US20060073328A1 (en) * 2004-09-21 2006-04-06 Andover Coated Products, Inc. Strapping system with non-elastic cohesive tape
EP1803809A3 (en) * 2005-08-12 2007-12-19 Abgenomics Corporation Modulation of peroxisome proliferator-activated receptors
CN101410097A (zh) 2006-01-24 2009-04-15 株式会社·R-技术上野 软明胶胶囊制剂
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
KR101950386B1 (ko) 2018-12-26 2019-02-20 성신여자대학교 연구 산학협력단 15-케토 프로스타글란딘 e2를 유효성분으로 포함하는 암 치료용 약학 조성물
WO2021066072A1 (ja) * 2019-09-30 2021-04-08 株式会社ブリヂストン ゴム組成物、ゴム－金属複合体、コンベヤベルト、ホース、クローラ及びタイヤ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
DE3869471D1 (de) * 1987-05-15 1992-04-30 Ueno Seiyaku Oyo Kenkyujo Kk Fiebersteigende zusammensetzung.
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
CA2041417A1 (en) 1991-11-02
KR910019620A (ko) 1991-12-19
KR970005174B1 (ko) 1997-04-14
EP0455448A2 (en) 1991-11-06
CA2041417C (en) 2002-05-21
DE69130586D1 (de) 1999-01-21
US5164415A (en) 1992-11-17
EP0455448A3 (en) 1992-07-08
ATE174221T1 (de) 1998-12-15
EP0455448B1 (en) 1998-12-09
TW209170B (enExample) 1993-07-11

Similar Documents

Publication Publication Date Title
DE69129921T2 (de) Behandlung von Katarakt mit 15-keto-Prostaglandinderivaten
CA2030345C (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
US5106869A (en) Prostaglandins of the f series
DE3850676T2 (de) Hypotensive okulare Mittel.
US5221763A (en) Prostaglandins of the F series
US5591887A (en) Prostaglandins of the F series
DE69213057T2 (de) Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
DE69118978T2 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
JPH04253910A (ja) 点眼用組成物
US7459583B2 (en) Method for providing a cathartic effect
DE69024744T2 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
KR101354771B1 (ko) 중추 신경계 질환 치료를 위한 방법 및 조성물
JP2511587B2 (ja) 眼科用医薬組成物
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
EP0454429B1 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
JPH04253913A (ja) 眼科用医薬組成物

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH